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Supraspinal modulation should not be defined 
merely on the process of modulation stage in pain 
pathways, but also involving other interconnect-
ing tracts and nuclei which are placed in several 
places above the medulla. The supraspinal area was 
deemed as fictitious, incoherent, and imaginary. In 
other hand, several animal and receptors experi-
ments conducted by biomolecular scientists have 
found different results. The exact region may not 
be concluded yet, but there are certainly complex 
processes occurring in upper pain pathways above 
the modulation stage consisting of the brain cortex 
and its related nuclei. These processes would be 
more active during continuous sensitization start-
ing from central sensitization and altered descend-
ing pain facilitation in pain processes which would 
lead to persistent pain and eventually chronic pain. 
The idea of elaborating this supraspinal modula-
tion theory is to build a solid combination of ideas 
and proven experiment results to occupy the mind 
of pain physicians and to be enlightened on the 
bigger perspective of pain pathways and manage-
ment. Experiments and clinical trials are still ongo-
ing and we have to be prepared to adopt the new 
advancements and technologies developed by other 
experts and scientists. 
Central Sensitization
There are many pathways that can lead to altered 
processing in the late phase that can cause central 
sensitization (CS). Ascending processes are usually 
the result of injury of psychophysical causes in 
which the nociceptive neurons are modified and 
the pain signal becomes sensitized. Descending 
processes usually are the result of modifications 
to supraspinal input. Moreover, pain blocks the 
proper functioning of catecholamines arising from 
the locus coeruleus, which project to the periaque-
ductal grey (PAG) and then to the dorsal horn in 
the spine, diminishing the descending inhibitory 
effect on nociception.1 
Many of those with central sensitization are also 
chronically stressed prior to the onset of pain. The 
theory of allostasis provides an explanation for these 
disorders that is strongly associated with hypocorti-
solism and dysregulation of the sympathetic nervous 
system, as well as serotonergic, opioid, and immuno-
logical functions. The receptiveness of the autonomic 
nervous system to physical and psychosocial stressors 
supports the homeostatic qualities of the pain system. 
Autonomic nervous system and psychosocial influ-
ence would be defined clearly in pain through the 
emotional motor system (EMS) mechanism.1-2
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Pain has always been a challenging issue in patients with acute and 
chronic conditions. Pain results from activation of sensory receptors 
specialized to detect actual or impending tissue damage. However, a 
direct correlation between activation and nociceptors and the sensory 
experience of pain is not always apparent. Emotional state, the degree 
of anxiety, attention and distraction, past experiences, memories, and 
many other factors can either enhance or diminish the pain experience.
Many active agents are used to block and alleviate pain sensation in 
acute and chronic settings. When an inadequate treatment for acute 
pain and neuralgia occurred, it would induce complex processes 
involving both central and peripheral sensitization contributing to 
persistent post-surgical pain and worsening neuralgia that would lead 
to chronic pain issues.
The important thing to be considered is that this pain process is an 
intertwined, interconnecting and sustainable process that could not be 
cut abruptly. Our aim is to remind professionals to accept that the pain 
pathway is not straight forward but rather a convoluting idea that can 
evolve and expand. Imagining areas could be defined one day through 
high technology advances and would lead us into defining the depth of 
this beautiful and complex pathway.
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Nociceptive Neurons
A-α and A-β fibres are large-diameter touch 
neurons responsible for registering proprioception 
and the ‘normal touch’ sensation. A-δ fibres are 
medium-diameter nociceptive neurons that trans-
mit noxious mechanical, thermal, and chemical 
stimuli. C-fibres are unmyelinated, small nocicep-
tors that are responsive to nociceptive input. When 
a stimulus evokes a signal that falls outside of a 
‘normal range’, the signal exceeds the threshold and 
the nociceptors are activated.1
Modulation of Sensation
There are two principal mechanisms in the 
modulation of sensation: selective attention and 
endogenous pain inhibition, that would be further 
explained in diffuse noxious inhibitory control 
(DNIC). The combination of these two mechanisms 
allows the brain to focus the attention on sensations 
arising from particular body region while tuning 
out sensory input from all other regions. Brain 
regions that are important in selective attention 
systems are the dorsolateral prefrontal cortex and 
the anterior cingulate cortex.1-2 
The rostral portion of the anterior cingulate cortex 
represents the visceral motor cortex with projections 
to a network made up of hypothalamic nuclei, amyg-
dala, and PAG. The output of this network reaches 
nuclei within the brain stem (rostral ventral medulla, 
locus coeruleus, raphe nuclei) with important roles 
in the regulation of pain modulation, arousal, and 
vigilance. This network has been referred to as the 
emotional motor system (EMS) and related to a 
specific set of parallel motor pathways governing 
somatic, autonomic, antinociceptive, and endocrine 
responses to stressors.1-2
Emotional Motor System (EMS)
Two components of the EMS play a crucial role in 
modulation of the pain experience in the context 
of conditioned fear: the amygdala and the PAG. 
The amygdala receives information about visceral 
stimuli not only from the visceral motor cortex, 
the lateral and basolateral nucleus of the amygdala 
receives projections from the thalamus, nucleus 
parabrachialis, and nucleus gigantocellularis. The 
latter input reaches the amygdala via noradrenergic 
projections from the locus coeruleus. The central 
nucleus of the amygdala sends projections to the 
lateral and ventrolateral portion of the PAG, medi-
ating opioid and non-opioid mediated analgesia. 
The connections between the lateral and basolateral 
nucleus of the amygdala and the central nucleus 
contain glutaminergic synapses involving both 
N-methyl-D-aspartate (NMDA) and non-NMDA 
receptors. The NMDA receptor is involved in the 
development of long-term potentiation, an import-
ant mechanism in the development of emotional 
memory in the amygdala.1-2
Pain Pathways 
The two major ascending pain pathways in mammals 
are the spinothalamic and the spinoparabrachial 
tracts. The thalamus and parabrachial nucleus 
receive information from projection neurons in 
various laminae of the dorsal horn and then relay 
this sensory information to cortical and amygdalar 
regions where the information is decoded as a pain-
ful stimulus.1  
Pain Modulation
Pain modulation is a degree to which a person reacts 
to pain which involves pain perception variability 
and influenced by endogenous and exogenous 
mechanism. The pain signal facilitation includes 
peripheral and central sensitization. The central 
sensitization has already been defined clearly 
above. While the pain signal inhibition includes 
spinal/segmental inhibition with its gate control 
theory, supraspinal modulation, which is the main 
topic of our discussion, and also pain modulation 
by opioid neurotransmitter could play some roles 
in pain modulation too.1 
Pain modulation likely exists in the form of a 
descending pain modulatory circuit with inputs 
that arise in multiple areas, including the hypo-
thalamus, the amygdala, and the rostral anterior 
cingulate cortex (rACC), feeding to the midbrain 
PAG region, and with outputs from the PAG to the 
medulla.1 
Supraspinal Modulation
Supraspinal modulation is one path of pain pathway 
that would be happened during pain modulation. It 
is a specific system in the pain pathway that blocks 
pain transmission in the central nervous system 
which consists of the PAG and periventricular areas, 
raphe magnus nucleus (RMN), and pain inhibitory 
complex (PIC). The PAG and periventricular areas 
of the mesencephalon and upper pons surround the 
aqueduct of Sylvius (periaqueductal) and portions 
of the third and fourth ventricles (periventricular). 
On the other hand, raphe magnus nucleus is a thin 
midline nucleus located in the lower pons and 
upper medulla, and the nucleus reticularis para-
gigantocellularis, located laterally in the medulla. 
The PIC is located in dorsal horn of spinal cord and 
consists of multiple short encephalinergic neurons 
that terminate on central endings of pain conduct-
ing afferent fibres.1,3-5 
The analgesia occurs in the thalamus, hypo-
thalamus and cerebral cortex by sending neuronal 
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signals to the PAG area. The PAG projects neurons 
contain aspartate and glutamate that stimulate 
raphe magnus nucleus. Then RMH projects sero-
tonergic neurons, this in addition to noradrenergic 
neurons projects from adjacent medulla to dorsal 
horn. They will block pain signals by activating 
PIC. When this complex is stimulated, encephalin 
is released and leads to pre- and postsynaptic inhi-
bition of pain transmission.1,3-5
Opioid Receptor Modulation
Besides the neurons and areas in supraspinal modu-
lation, this process also related to opioid receptor 
modulation. The opioid peptides consist of endor-
phin, encephalin, dynorphin, and endogenous 
morphine. Neurons using endorphin or encephalin 
are found in PAG where they inhibit GABA-nergic 
interneurons that normally suppress the anti-noci-
ceptor neurons. Encephalin is used by interneurons 
in lamina II responsible for inhibiting the lami-
na-I nociceptor-specific spinothalamic neurons. 
Dynorphin could be found in hypothalamus, PAG, 
reticular formation, and dorsal horn, while endog-
enous morphine is in terminals forming synapses 
with neurons having µ-opioid receptors in pain 
modulation.1-2,5
Brain Pain Matrix
Other researchers have used imaging studies to 
suggest that the pain matrix constantly activates 
the brain areas by noxious stimuli. These areas 
often include the rACC, posterior cingulate cortex 
(pCC), somatosensory cortex 1 and 2, the insula, 
amygdala and thalamus, and the PAG. The pain 
matrix concept conceptually represents a collection 
of brain regions that are involved in neurological 
functions, including cognition, emotion, motiva-
tion, and sensation as well as pain.1-2
On-Off Cells of Rostral Ventromedial Medulla
Descending projections from the RVM course 
through the DLF to the spinal dorsal horn and 
form synaptic connections with primary afferent 
terminals and second-and third-order neurons 
that transmit nociceptive signals to supraspinal 
sites as well as with interneurons and thus are well 
situated to modulate nociceptive inputs. Studies by 
Fields and colleagues led to the identification of a 
population of RVM neurons that increase firing just 
prior to the initiation of nociceptive reflex (known 
as on-cells) and another population of neurons was 
found to decrease firing (known as off-cells). Both 
of them were sound to project to the spinal dorsal 
horn, indicating possible exerting modulatory 
influences on nociceptive inputs.1
Serotonergic Role of Pain Modulation
Stimulation of the PAG or RVM cause release 
of serotonin in the spinal cord, and intrathecal 
administration of 5-HT agonists elicited antino-
ciception, whereas intrathecal 5-HT antagonists 
attenuated SPA from the RVM. Such studies led 
to the assumption that RVM provided descending 
serotonergic pain modulation from RVM. The 
effect of spinal serotonin can be either inhibitory or 
facilitatory, depending on the receptor subtype acti-
vated. Although several observations indicate an 
important serotonergic role for pain modulation, 
the precise spinal mechanism involved remains 
unclear.1,3-5
Adrenergic Receptors in Pain Modulation
There are also findings that suggest a contribution 
of norepinephrine in antinociception associated 
with descending inhibition. While neither PAG nor 
RVM contain noradrenergic neurons, both regions 
communicate with noradrenergic sites related to 
pain modulation including A5 (locus coeruleus), 
A6, and A7 (Kölliker-Füse) nuclei. Activation of 
α-adrenergic receptors has been shown to inhibit 
nociceptive transmission at the level of the spinal 
cord through presynaptic activity, inhibiting release 
of excitatory neurotransmitters from primary 
afferent terminal, as well as through postsynaptic 
sites.1,3-4
Stress-induced Analgesia (SIA) Associated 
with Antinociceptive Effects
Other mechanisms in pain modulation by mediat-
ing suppression of pain by stress have been inten-
sively studied. Stress-induced analgesia (SIA) is 
associated with elevated PAG levels of B-endorphin, 
and microinjection of µ-receptor antagonists into 
the PAG or RVM abolished SIA. Opioid microin-
jection into the amygdala elicits antinociception 
that is blocked by lidocaine in either the PAG or 
RVM. These led to the conclusion that SIA can be 
opioid sensitive and mediated through descending 
inhibitory pathways from amygdala, the PAG, and 
through RVM projections to the spinal cord.1-4 
Descending Pain Facilitation
Activation of descending facilitation after peripheral 
nerve injury has been associated with pronocicep-
tive changes in the spinal cord. Peripheral nerve 
injury resulted in enhanced capsaicin-evoked release 
of calcitonin gene-related peptide (CGRP) from 
primary afferent fibres in spinal cord sections and 
upregulation of spinal dynorphin to pathological 
levels. Manipulations that abolished descending facil-
itation also abolished dynorphin upregulation and 
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enhanced release of CGRP. Recent studies revealed 
that increased concentration of spinal dynorphin can 
stimulate neurons through increased calcium influx, 
unexpectedly mediated through the bradykinin 
receptors. Blockade of spinal bradykinin receptors 
inhibited behavioural signs of neuropathic pain, 
visceral pain, and diminished central sensitization.1,3-5
Diffuse Noxious Inhibitory Control (DNIC) 
Role in Chronic Pain Syndromes
Recent concept of DNIC was formulated from 
observations made with recordings of spinal dorsal 
horn units in anesthetized rats in response to 
peripheral stimuli applied to various parts of the 
body. Importantly, DNIC was not demonstrated in 
dorsal horn units that responded solely to noxious, 
proprioceptive, or innocuous inputs, indicating a 
requirement for convergent neurons receiving both 
noxious and innocuous stimuli. 1-4
Novelty of Drugs as Targets of Pain 
Management in Supraspinal Modulation
The concept of supraspinal modulation which 
consists of a descending pain modulatory system 
provides many targets for the development of anal-
gesic drugs or adjuncts that enhance the effects 
of existing analgesics. Opioids act throughout the 
neuraxis and can relieve pain through activities at 
cortical and subcortical sites, as well as by activating 
descending pain inhibitory circuits. Accordingly, 
α2-adrenergic receptor agonists have been shown 
to produce antinociception as well as to potentiate 
the antinociceptive effects of opioids. Moreover, by 
increasing spinal noradrenergic activity, tricyclic 
antidepressants and other selective noradrenergic 
reuptake inhibitors enhance the analgesic effect of 
opioids and show clinical efficacy against neuro-
pathic pain. It was recently shown that the clinical 
efficacy of gabapentin may be due to its activation 
of descending noradrenergic systems and release of 
norepinephrine in the spinal cord. The cyclooxy-
genase (COX) inhibitors exert an analgesic effect by 
inhibition of prostaglandin E-2 (PGE2) synthesis, 
this reducing peripheral and central sensitization. 
Recent studies also indicate that inhibition of COX 
in the PAG promotes an opioid-mediating descend-
ing pain inhibition.1,3-5
Advances in Imaging and Technological 
Studies for Pain Modulation
The advent of neuroimaging studies and techno-
logical advances allowing increased spatial and 
temporal resolution has contributed greatly to our 
changing perceptions of how pain is integrated and 
modulated in the central nervous system. Early 
animal studies described a linear system of pain 
modulation from the PAG through the RVM and 
descending to the spinal cord in which envision a 
complex pain matrix that includes important corti-
cal regions and elements of the limbic system as 
well as midbrain and medullary sites. The concept 
of a top-down pain modulation system accounts 
for, or contributes to, pain relief as seen with the 
placebo effect, stress, DNIC, and the actions of 
pain-relieving drugs, such as opioids, NSAIDs, 
reuptake blockers, and possibly gabapentinoids. 
These modulatory pathways help to explain how 
personal experience and emotional state, as well as 
societal beliefs, may alter the experience of pain.1-3
CONCLUSION
Supraspinal modulation, which was theoretically 
explained many years ago, was not only a theory 
but has developed into many studies and research 
targets. We have to accept that we could not adhere 
to solid and stiff theory and conventional pain 
management anymore. Pain management would 
not only be the scope of pain physician but also 
open up to better challenges for biomolecular scien-
tists, neuroimaging researchers and even psycho-
social experts. Collaborative works and projects 
in this unique supraspinal modulation would lead 
us to other aspects, other stages of pain pathways, 
other receptors, new neurotransmitters that would 
ask for many shared thoughts, ideas and improved 
theories. The ‘fictional’ supraspinal modulation 
surely would not be fictitious anymore and could 
be defined in a progressive objective and therapies.
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